Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1549
Full metadata record
DC FieldValueLanguage
dc.contributorCommons, Robert J.en_US
dc.contributorMcCarthy, James S.en_US
dc.contributorPrice, Ric N.en_US
dc.date.accessioned2020-08-05T00:09:52Z-
dc.date.available2020-08-05T00:09:52Z-
dc.date.issued2020-
dc.identifier.govdoc01505en_US
dc.identifier.urihttp://hdl.handle.net/11054/1549-
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2020-07-31T01:29:43Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2020-08-05T00:09:52Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2020-08-05T00:09:52Z (GMT). No. of bitstreams: 0 Previous issue date: 2020en
dc.titleTafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.en_US
dc.typeJournal Articleen_US
dc.type.specifiedArticleen_US
dc.bibliographicCitation.titleMedical Journal of Australiaen_US
dc.bibliographicCitation.volume212en_US
dc.bibliographicCitation.issue4en_US
dc.bibliographicCitation.stpage152en_US
dc.bibliographicCitation.endpage153.e1.en_US
dc.subject.healththesaurusTAFENOQUINEen_US
dc.subject.healththesaurusMALARIAen_US
dc.subject.healththesaurusPLASMODIUM VIVAXen_US
dc.subject.healththesaurusG6PDen_US
dc.identifier.doihttps//doi.org/10.5694/mja2.50474en_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.